Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the study record remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA sitewide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check16 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and showing a generic error screen instead of the usual content. This indicates an access or permissions problem rather than an update to the study information.SummaryDifference22%

- Check65 days agoChange DetectedThe page shows an updated revision tag: from v3.6.5 to v3.6.6, indicating a deployment of the latest site template. The change does not modify study content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.